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a  b  s  t  r  a  c  t
Human  biomonitoring  (HBM)  is  an effective  tool to assess  human  exposure  to  environmental  pollutants,
but  comparable  HBM  data  in Europe  are  lacking.  In  order to  expedite  harmonization  of  HBM  studies  on  a
European scale,  the  twin  projects  COPHES  (Consortium  to Perform  Human  Biomonitoring  on  a  Europeanccepted 30 January 2017 Scale)  and DEMOCOPHES  (Demonstration  of  a  study  to Coordinate  and  Perform  Human  Biomonitoring
on  a European  Scale)  were  formed,  comprising  35  partners  from  27  European  countries.eywords: In  COPHES  a research  scheme  and  guidelines  were  developed  to  exemplarily  measure  in  a  pilot  study
EMOCOPHES/COPHES
uman biomonitoring
ermany
ercury
mercury  in  hair,  cadmium,  cotinine  and  several  phthalate  metabolites  in urine  of  6–11 year  old  chil-
dren  and their  mothers  in an urban  and  a rural  region.  Seventeen  European  countries  simultaneously
conducted  this  cross-sectional  DEMOCOPHES  feasibility  study.
Abbreviations: AM,  arithmetic mean; ATSDR, Agency for Toxic Substances and Disease Registry; BE, biomonitoring equivalent; CAPI, computer assisted personal interview;
I,  conﬁdence interval; COPHES, Consortium to Perform Human Biomonitoring on a European Scale; DEMOCOPHES, Demonstration of a Study to Coordinate and Perform
uman  Biomonitoring on a European Scale; DFG, German Research Foundation; EFSA, European Food Safety Authority; ESB, German Environmental Specimen Bank; ETS,
nvironmental tobacco smoke; EQUAS, external quality assessment schemes; GerES, German Environmental Survey; G-EQUAS, German External Quality Assessment Scheme;
M,  geometric mean; HBM, human biomonitoring; HBM-I, HBM-II value, human biomonitoring value I, human biomonitoring value II; ICI, interlaboratory comparison
nvestigation; ICP-MS, inductively coupled plasma quadrupole mass spectrometry; IPA, Institute for Prevention and Occupational Medicine of the German Social Accident
nsurance; IPASUM, Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine; JEFCA, Joint FAO/WHO Expert Committee on Food Additives; LOQ,
imit  of quantiﬁcation; N, sample size; MAK-Commission, Permanent Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area;
in.,  minimum value; max., maximum value; MRL, minimal risk level; PVC, poly-vinyl chloride; P10, P25, P50, P75, P90, P95, percentiles; QAU, COPHES Quality Assurance
nit;  REACH, European chemicals legislation concerning the registration, evaluation, authorisation and restriction of chemicals (regulation EC 1907/2006); RfD, reference
ose;  SOP, standard operating procedure; TDI, tolerable daily intake; UBA, German Environment Agency; USEPA, United States Environmental Protection Agency.
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Cadmium
Cotinine
Phthalates
The  German  study  population  was taken  in the  city  of Bochum  and  in the Higher  Sauerland  District,  com-
prising  120  mother-child  pairs.  In the  present  paper  features  of  the  study  implementation  are  presented.
German  exposure  concentrations  of  the  pollutants  are  reported  and  compared  with  European  average  con-
centrations  from  DEMOCOPHES  and  with  those  measured  in  the representative  German  Environmental
Survey  (GerES  IV).
German  DEMOCOPHES  concentrations  for mercury  and  cotinine  were  lower  than  the  European  average.
However,  47%  of  the  children  were still  exposed  to environmental  tobacco  smoke  (ETS)  outside  their
home,  which  gives  further  potential  for enhancing  protection  of  children  from  ETS.
Compared  with  samples  from  the  other  European  countries  German  participating  children  had  lower
concentrations  of the  phthalate  metabolites  MEP  and  of  the sum  of  3  DEHP-metabolites  (MEHP,  5OH-
MEHP and  5oxo-MEHP),  about  the  same  concentrations  of the  phthalate  metabolites  MBzP  and  MiBP  and
higher  concentrations  of the phthalate  metabolite  MnBP.  2.5%  of the  German  children  had  concentrations
of the sum  of 4 DEHP-metabolites  and  4.2%  had  concentrations  of MnBP  that  exceeded  health  based
guidance  values,  indicating  reasons  for concern.
Continuous  HBM  is necessary  to  track changes  of  pollutant  exposure  over time.  Therefore  Germany  will
continue  to cooperate  on the  harmonisation  of European  human  biomonitoring  to  support  the  chemicals
regulation  with  the  best  possible  exposure  data  to protect  Europe’s  people  against  environmental  health
risks.
ished
1
o
s
s
m
m
b
G
m
E
i
2
a
a
t
E
e
p
a
E
a
b
P
C
H
a
f
(
(
a
n
s
p
e
2
p
c
a
w
m©  2017  The  Authors.  Publ
. Introduction
Human biomonitoring (HBM) focuses on measuring the uptake
f chemicals by the human body and on assessing the internal expo-
ure of humans. HBM considers all routes of uptake and all relevant
ources, making it an ideal instrument for risk assessment and risk
anagement and thus being a tool for scientists as well as for policy
akers. In Germany, human exposure to chemicals is determined
y HBM with two main instruments: the population representative
erman Environmental Survey (GerES) and the German Environ-
ental Specimen Bank (ESB) (Kolossa-Gehring et al., 2012). In
urope, several other countries have also conducted HBM studies
n the past (Castano et al., 2012; Cerna et al., 2012; Frery et al.,
012; Hohenblum et al., 2012; Schoeters et al., 2012). However,
 comparison of the derived data is difﬁcult because of different
pproaches in study methodology, analytical methods used and
arget populations investigated.
Since environmental chemicals are widespread throughout
urope and because HBM will enable the evaluation of the
ffectiveness of the European chemicals legislation REACH (Euro-
ean chemicals legislation concerning the registration, evaluation,
uthorisation and restriction of chemicals, EC 1907/2006), the
uropean Commission called for the development of a coherent
pproach to HBM in Europe in close cooperation with the Mem-
er States. As a result, the twin projects COPHES (Consortium to
erform Human Biomonitoring on a European Scale) and DEMO-
OPHES (Demonstration of a study to Coordinate and Perform
uman Biomonitoring on a European Scale) were set up to build
 sustainable framework and to demonstrate that HBM can be per-
ormed in a coherent and harmonized approach throughout Europe
Joas et al., 2012).
COPHES constituted 35 partners from 27 European countries
Joas et al., 2015). They developed a study design, a study protocol
nd guidelines and standard procedures for all aspects of a harmo-
ized European pilot study: recruitment and ﬁeldwork, specimen
ampling, chemical analysis, data management, analysis and inter-
retation, ethics and communication (Becker et al., 2014; Casteleyn
t al., 2015; Esteban et al., 2015; Exley et al., 2015; Fiddicke et al.,
015; Schindler et al., 2014). The members of COPHES decided to
erform a cross sectional study and to measure mercury in hair,
admium, cotinine and phthalate metabolites in urine of children
ged 6–11 years and their mothers. The biomarkers of exposure
ere selected because of availability of analytical methods, infor-
ation on toxicokinetics and health based guidance values, as well by  Elsevier  GmbH.  This  is an  open  access  article  under  the  CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
as their potential to increase public and political awareness, and
in order to gather experience with less common analytical pro-
cedures. Mercury, cadmium and cotinine were chosen because
sufﬁcient analytical experience and knowledge on toxicokinetics
exist. Phthalate metabolites were included to take into account
the increasing awareness as well as the level of analytical expe-
rience required for testing. The selected biomarkers can reliably be
determined in hair and urine samples, which are relatively easy to
sample and do not require highly trained technicians. The 17 Euro-
pean countries participating in the pilot study DEMOCOPHES were
Belgium, Cyprus, Czech Republic, Denmark, Germany, Hungary,
Ireland, Luxembourg, Poland, Portugal, Romania, Slovenia, Slovak
Republic, Spain, Sweden, Switzerland, and United Kingdom.
Germany has long-lasting experience on HBM surveys. The Ger-
man  Environment Agency (UBA) participated in both the COPHES
and DEMOCOPHES projects in order to make these efforts applica-
ble throughout Europe, to transfer experience and standards to the
European level and to contribute to build a European-wide HBM
framework. In COPHES, UBA led the development of protocols and
standard operating procedures (SOP) for participant recruitment
and ﬁeldwork (Becker et al., 2014) and UBA was responsible for
the conduct of DEMOCOPHES in Germany. The establishment of
a harmonized HBM in Europe is continued by the European Joint
Programme “HBM4EU” launched by the European Union in the
Framework Program for Research and Innovation, Horizon 2020,
and coordinated by the UBA. The overarching goal of which is to
generate knowledge, to inform the safe management of chemi-
cals, and consequently protect human health in Europe. HBM data
will build the basis to assess the risks from human exposure to
chemicals and the resulting health impacts. By means of intensive
communication with policy makers HBM4EU will promote the fur-
ther development and design of new chemicals policies as well
as the evaluation of existing measures. HBM4EU follows the key
objectives to harmonize procedures for HBM across 26 countries,
provide policy makers with comparable data on human inter-
nal exposure to chemicals and mixtures of chemicals in Europe,
link data on internal exposure to chemicals to aggregate external
exposure and identify exposure pathways and upstream sources,
generate scientiﬁc evidence on the causal links between human
exposure to chemicals and negative health outcomes, and adapt
chemical risk assessment methodologies to use HBM data and
account for the contribution of multiple external exposure path-
ways to the total body burden of various chemicals.
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The present paper reports the results for the German DEMO-
OPHES sample, the lessons learned from which will inform
BM4EU. The implementation of the study in Germany is described
nd the concentrations of the selected biomarkers of exposure
re reported. These results are compared with the total European
esults (Den Hond et al., 2015) and with data obtained in the repre-
entative fourth German Environmental Survey (GerES IV) (Schulz
t al., 2012a). Factors associated with exposure concentrations are
resented. Particular attention is drawn on the proportion of par-
icipants exceeding health based guidance values and thus being
otentially at risk for health impacts.
. Material and methods
The German study protocol was elaborated based on the Euro-
ean consensus protocol of COPHES (Casteleyn et al., 2015).
ccording to this common protocol each participating country
ecruited 120 mother-child pairs, half from an urban and half from
 rural area, took scalp hair and morning urine samples and ana-
yzed them for mercury (hair) and cadmium, cotinine and phthalate
etabolites (urine). The mother and child pairs were included in
he analysis if they gave informed consent, met  the inclusion cri-
eria, provided hair and morning urine samples and answered a
uestionnaire.
.1. Study population and ﬁeldwork
According to the COPHES guidelines for recruitment (Becker
t al., 2014), the selection of the German participants followed a
wo-step procedure. First, the German federal state North Rhine-
estphalia was chosen as the study region. Secondly, population
ensity served as a criterion to choose an urban and a rural sam-
ling location. In North Rhine-Westphalia the city of Bochum was
t the upper degree of urbanization and the Higher Sauerland Dis-
rict was at the lower degree of urbanization, so these two  sites
ere chosen as the urban and the rural sampling location.
As children were the primary target group, the selection of
articipants focused on the child: children 6–11 years old were
elected randomly via the respective inhabitant registries, a resi-
ent registration kept by the local public administration. The aim
as to include 10 children of each age and of equal sex distribution
n both the urban and the rural locations.
Besides the age of the child, further inclusion and exclusion cri-
eria were: mother’s age 45 years or younger; mother and child
iving in the same location for at least 5 years; only one child per
other eligible; only children who live at least 16 days per months
ith the mother; sufﬁcient German language ability; not living in
 hospital, institution or being homeless; and no metabolic distur-
ances or abnormal urine excretion.
Detailed study information, urine-vessels and instructions on
ow to collect the ﬁrst morning urine sample were sent to the par-
icipating mother-child pairs by mail. During the home visit shortly
fterwards, the interviewers received the morning urine samples
rom the mother and the child and took scalp hair samples from
oth. Additionally, the mother answered a face-to-face interview,
ncluding questions on socio-demography, nutrition and exposure
elated habits and behavior.
The Department of Hygiene, Social and Environmental
edicine, Ruhr-University Bochum, Germany, conducted the ﬁeld
ork on behalf of the UBA. The interviewers participated in the
OPHES training sessions on all aspects of ﬁeldwork, which was
andatory for all participating countries in order to ensure the
ecessary harmonized performance of the study.nd Environmental Health 220 (2017) 686–696
The study was approved by the ethics committee of the Faculty
of Medicine of the Ruhr-University Bochum (No. 4040-11) and the
data protection ofﬁcer of the Ruhr-University Bochum.
Sampling took place between September and December 2011.
2.2. Biospecimen collection and handling
COPHES instructions for urine and hair sampling, stor-
age and shipping were provided in COPHES deliverables
and in the ﬁeldwork training sessions. They can be found
on the COPHES/DEMOCOPHES website (http://www.eu-hbm.
info/cophes/project-work-packages/trainings-agendas-and-
presentations).
In Germany, all ﬁrst morning urine samples were collected in
vessels that were prewashed with 2% nitric acid. After collecting
the urine samples, the participants were asked to store the ves-
sels refrigerated or in a cool place until they were handed over
to the interviewers. The morning urine samples were transported
refrigerated, aliquoted and stored at −18 ◦C until analysis.
Hair samples were cut close to the head surface using titanium
scissors. Each hair sample was  stored in a paper envelope, placed
in a plastic bag at room temperature.
At the end of ﬁeldwork, samples were arranged completely
at random for chemical analysis. Subsequently the interviewers
sent the urine samples frozen to the respective laboratories and
delivered the hair samples to the analysing laboratory at room
temperature.
2.3. Laboratory chemical analyses
Urine and hair samples were analyzed by laboratories, which
used validated methods and participated in the interlaboratory
comparison investigations (ICI) and external quality assessment
schemes (EQUAS) guided and evaluated by the COPHES Quality
Assurance Unit (QAU) (Esteban et al., 2015; Schindler et al., 2014) to
ensure comparability between the measurements of the different
European laboratories involved.
2.3.1. Mercury
The analysis of mercury in the hair samples was performed by
the Department of Hygiene, Social and Environmental Medicine,
Ruhr-University Bochum. The 3 cm of hair which were closest to
the scalp were analyzed with the recommended method of the
respective COPHES deliverable, using the Direct-Mercury-Analyzer
DMA-80 of MLS  GmbH, Leutkirch, Germany. Hair samples were cut
in pieces of 2–4 mm.  About 3.5 mg  were introduced directly into
the analyzer without any pretreatment. They were dried, thermally
decomposed, trapped on a gold amalgamator and quantitatively
determined using atomic absorption spectrophotometry at 254 nm.
The limit of quantiﬁcation (LOQ) was 0.003 g/g.
2.3.2. Cadmium
The Institute and Outpatient Clinic of Occupational, Social
and Environmental Medicine (IPASUM), Friedrich-Alexander-
Universität Erlangen-Nürnberg, Erlangen, quantiﬁed cadmium
in the urine samples. Cadmium analysis was performed by
using inductively coupled plasma quadrupole mass spectrome-
try (Quadrupole ICP-MS) with an ICP-MS of PerkinElmer, NexION
350D. This method was  recommended by COPHES and evaluated by
the Permanent Senate Commission for the Investigation of Health
Hazards of Chemical Compounds in the Work Area (MAK Commis-
sion) of the German Research Foundation (DGF) and published by
Wiley-VCH (Schramel et al., 1999) The LOQ was  0.05 g/L.
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Table  1
Phthalate metabolites selected for European comparison in the DEMOCOPHES study.
Parent phthalate Full name of parent phthalate Primary metabolite Secondary metabolite Full name of metabolite
Low molecular weight phthalates
DEP Di-ethyl phthalate MEP Mono-ethyl phthalate
BBzP  Butyl benzyl phthalate MBzP Mono-benzyl phthalate
DnBP Di-n-butyl phthalate MnBP Mono-n-butyl phthalate
DiBP  Di-isobutyl phthalate MiBP Mono-isobutyl phthalate
High  molecular weight phthalate
DEHP Di-(2-ethyl-hexyl) phthalate MEHP Mono-(2-ethyl-hexyl) phthalate
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i.3.3. Cotinine
The Institute for Prevention and Occupational Medicine of the
erman Social Accident Insurance (IPA) at the Ruhr-University
ochum carried out the analysis of cotinine in the urine sam-
les. Two-dimensional liquid chromatography-mass spectrometry
ith isotope dilution quantiﬁcation was applied as established by
PA. In short, urine samples were spiked with an internal standard
olution of cotinine-d3 and chromatographically resolved in a two
olumn assembly consisting of a Waters Oasis
®
HLB cartridge col-
mn (2.1 × 20 mm;  25 m)  and a Hypercarb (Thermo Scientiﬁc)
2.1 × 100 mm;  3 m).  Mass spectrometric detection and quantiﬁ-
ation was performed using a Waters Quattro Premier XE triple
uadrupole mass spectrometer in positive ionization mode. The
OQ was 0.1 g/L for cotinine.
.3.4. Phthalates
IPA also analyzed phthalate metabolites in the urine sam-
les. Based on the DFG method (Koch and Angerer, 2008), the
hthalate metabolites were determined by multidimensional liq-
id chromatography with tandem mass spectrometric detection
Kasper-Sonnenberg et al., 2012; Koch et al., 2013). The limits of
uantiﬁcation ranged between 0.2 and 1.0 g/L, depending on the
espective metabolite. All metabolites selected for European eval-
ation by DEMOCOPHES and their acronyms are summarized in
able 1.
.3.5. Creatinine
The quantiﬁcation of creatinine in the urine samples was  per-
ormed by IPASUM by the method of Jaffé (Blaszkiewicz and
iesenhoff-Henze, 2010).
.4. Statistical analysis
Characteristics of the biomarker distributions (sample size (N),
> LOQ, minimum (min.), maximum (max.), arithmetic mean (AM)
eometric mean (GM), conﬁdence intervals (CI) and percentiles (P))
ere calculated for mothers and children separately. These charac-
eristics are summarized in the Supplementary Tables 1 and 2. For
iomarkers in urine, volume based as well as creatinine adjusted
oncentrations are presented. Urine samples with a creatinine con-
entration lower than 300 mg/L or above 3000 mg/L were excluded
rom the analyses (WHO, 1996). Concentrations below the LOQ of
he respective analytical method were assigned a value equal to half
f the LOQ. Due to the skewed (approximately log-normal) distri-
ution of the biomarker concentrations, GM is a parameter more
uitable for assessment than AM.  Although the European countries
iffer considerably in the number of inhabitants, 120 mother-child
airs from each country were included in the statistical calcula-
ions, except for Cyprus and Luxembourg, which contributed only
alf because of their very small populations. No further weight-
ng of the country data was applied (Den Hond et al., 2015).5OH-MEHP Mono-(2-ethyl-5-hydroxy-hexyl) phthalate
5oxo-MEHP Mono-(2-ethyl-5-oxo-hexyl) phthalate
5cx-MEPP Mono-(2-ethyl-5-carboxy-pentyl) phthalate
Differences between the German and the European GMs  were
assessed by looking at the overlaps of the CIs.
Speciﬁcally for each biomarker socio-demographic and behav-
ioral factors as well as conditions of living which are suspected
either by scientiﬁc knowledge or by biological plausibility to be
associated with the biomarker concentration were analyzed in
bivariate statistical analyses: differences of the GM of the respec-
tive subgroups were tested for signiﬁcance via t-tests or one-way
analyses of variance, such as differences between mothers and chil-
dren, and differences by number of smokers in household. The
10–18 speciﬁc factors analyzed are listed by Den Hond et al., 2015;
Supplemental Material.
Correlations between the values of each mother and her child
were analyzed for each biomarker using Spearman rank correlation
coefﬁcients.
Statistical analyses were performed with the SPSS statistical
package (version 20).
3. Results and discussion
3.1. Study population and ﬁeldwork in Germany
The recruitment results are shown in Table 2. A total of 430
children in the urban region and 433 children in the rural region
were invited to participate with their mothers in the study. Out of
these, responses were received from 256 (urban) and 176 (rural)
of the invited families, 88 (urban) and 99 (rural) of them expressed
their willingness to participate. Twenty-eight (urban) and 39 (rural)
mother-child pairs were excluded either because they met  exclu-
sion criteria or because of oversampling in individual one-year age
groups of the children. The recruitment process ﬁnally resulted in
the required number, age and sex distribution and in the character-
istics of the participating mother-child pairs as shown in Table 3.
Among the study population three mothers showed urinary cre-
atinine levels below 300 mg/L while one mother had a creatinine
level above 3000 mg/L. The urine analyses of these four mothers
were excluded from the statistical analyses since their urine levels
did not meet the inclusion criteria.
For all steps of the ﬁeldwork COPHES had developed a study pro-
tocol in a systematic and transparent approach (Becker et al., 2014).
Whenever necessary, the participating countries had the possibil-
ity to adapt certain study elements insofar this did not jeopardize
the comparability of results. Adaptations of study elements in the
German study conduct and observations are described below, adap-
tations by other countries are reported by Fiddicke et al. (2015):
- In Germany, the procedure of selection via inhabitant registries
is well established and was  applied successfully in several GerES
(Schulz et al., 2007). Therefore, this approach was applied in
the German DEMOCOPHES study. Although the participation rate
with 14% was  only moderate (Table 2), it yielded in the required
number of participants and had the advantage that a strictly
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Table 2
Recruitment and participation in DEMOCOPHES in Germany.
Study area (sampling location) Urban: City of Bochum North Rhine-Westphalia Rural: Higher Sauerland District North Rhine-Westphalia
Population density 3900 inhabitants/km2 80 inhabitants/km2
Invited families N = 430 N = 433
Families responding (by mail, telephone or personal contact) 60% (N = 256) 41% (N = 176)
Families willing to participate 21% (
Families excluded (exclusion criteria, oversampling) 7% (N
Participating families 14% (
Table 3
Characterization of the German DEMOCOPHES study population.
Children Mothers
N 120 120
Study area, N
Urban 60 60
Rural 60 60
Sex, N
Male 60 –
Female 60 120
Age, years
Median (Min.–Max.) 8 (6–11) 40 (28–45)
Age group, N
6–8 years 67 (56%) –
9–11 years 53 (44%) –
≤35 years – 21 (18%)
36–40 years – 43 (36%)
>40 years – 56 (47%)
Urinary creatinine
Concentration, mg/L, Median (min.–max.) 1119 (308–2668) 1070 (200–3162)
<300 mg/L (exclusion criterion), N – 3
>3000 mg/L (exclusion criterion), N – 1
Body Mass Index, kg/m2
Median (Min.–Max.) 15.8 (11.8–26.5) 23.6 (18.3–50.8)
Smoking habits, N
Daily smoker 0 21 (18%)
Occasional smoker 0 0
Former smoker 0 28 (23%)
Never smoker 120 (100%) 71 (59%)
Environmental tobacco smoke, N
(former and never-smokers only)
At home 10 (8%) 6 (6%)
Elsewhere 56 (47%) 66 (67%)
Fish consumption, N
-
-Several times per week 5 (4%) 9 (8%)
Once a week or less 115 (96%) 111 (93%)
random population sample could be chosen. Recruitment via
schools as accomplished in 14 other DEMOCOPHES countries did
not necessarily result in higher participation rates (Fiddicke et al.,
2015).
 In Germany, several mothers willing to participate had to be
excluded because of their age. A comparable rate of exclusion
because of mother’s age was also reported in other countries
(Fiddicke et al., 2015). The mother’s age limit as an inclu-
sion/exclusion criterion should be reconsidered in future studies,
when children aged 6–11 years and their mothers are targeted as
the study population.
 With only three exceptions, home visits could be realized in the
German study population. In contrast to visits at an examina-
tion center, home visits offer the opportunity to collect additional
environmental samples in the residence for ambient exposure
assessment. The high rate of successfully completed home visits
implies that the extension of ambient exposure assessment can be
integrated in the study design of future studies. Additional ambi-
ent exposure assessment was also applied successfully in several
GerES since 1985 (Schulz et al., 2007, 2012a).N = 88) 23% (N = 99)
 = 28) 9% (N = 39)
N = 60) 14% (N = 60)
- The ethical approval by the Ruhr University, Bochum, required the
non-responder procedure of the COPHES guidelines to be modi-
ﬁed. First, the reply card had to be supplemented with the option
to refuse study participation completely. Secondly, detailed infor-
mation on the objective of non-responder questions had to be
included in the study information.
Altogether the common COPHES study protocol for DEMO-
COPHES could be applied in most parts using the preferred choice
of options for recruitment and ﬁeldwork (Becker et al., 2014). Only
a few minor adaptations had to be made but no adaptations inter-
fering with comparability were necessary.
3.2. Mercury in hair
The mercury content in the hair samples of the German and
of all participants of the 17 European countries is shown in
Table 4. Mercury was  detected in the hair of all participating
German children and their mothers. The concentrations ranged
from 0.007 g/g to 1.13 g/g for the children and from 0.008 g/g
to 1.35 g/g for the mothers (Supplementary Table 1). The GM
of mercury concentrations was signiﬁcantly higher in mothers
(0.109 g/g) than in children (0.055 g/g). Compared with the GM
of all 17 DEMOCOPHES countries, the German mercury concentra-
tions were considerably lower, both for children and for mothers
(GM 0.055 g/g versus 0.145 g/g for children and 0.109 g/g
versus 0.225 g/g for mothers, Table 4). The individual mercury
concentrations of the mothers and their children in Germany were
considerably correlated (r = 0.425, p < 0.001, Table 5). The associa-
tions of several factors with mercury concentration in hair were
analyzed. Besides age, sex of the child, highest educational level
of the family and area of residence, which were analyzed for each
biomarker, additional factors were chosen which were suggested to
be associated with mercury concentration in hair. No sex difference
in the mercury concentration of the children’s hair was  observed.
Only the frequency of ﬁsh consumption correlated with mercury
concentration in hair, both for the mothers and for the children
(Fig. 1). As mercury found in hair is typically organic, teeth with
amalgam ﬁllings, broken thermometers and energy saving lamps
were not associated with the mercury concentrations in children’s
or mother’s hair in this sample.
To interpret exposure levels, the hair mercury concentrations
from this study are compared to existing health based guidance
values. For mercury in hair several guidance values are available.
None of the German children and mothers exceeded the provisional
guidance value of 2.3 g/g hair published by the Joint FAO/WHO
Expert Committee on Food Additives (JEFCA) (WHO,  2004). When
compared to the value of 1.0 g/g hair, which is derived from
the reference dose set by the United States Environmental Protec-
tion Agency (USEPA) (NRC, 2000), one mother and one child (not
related) exceeded this value, resulting in 0.8% for mothers and 0.8%
for children, respectively (Table 7).The German mercury results are in the range of most of
the Northern and Central European countries (Den Hond et al.,
2015). The widespread difference in mercury exposure among the
European countries and the strong correlation of hair mercury
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Table  4
Frequency of quantiﬁcation, geometric mean with 95% conﬁdence interval (in parentheses) of mercury in hair and urinary cadmium and cotinine of children and their
mothers  in DEMOCOPHES in Germany and in all DEMOCOPHES countries.
DEMOCOPHES in Germany All DEMOCOPHES countriesa
% >LOQ GM (95% CI) % >LOQ GM (95% CI)
Mercury (g/g hair) Children (N = 120) 100 0.055 (0.046–0.066) Children (N = 1836) 85.9 0.145 (0.139–0.151)
Mercury (g/g hair) Mothers (N = 120) 100 0.109 (0.091–0.132) Mothers (N = 1.839) 90.5 0.225 (0.216–0.234)
Cadmium (g/L urine) Children (N = 119) 61 0.051* (0.045–0.058) Children (N = 1698) 70.1 0.071 (0.069–0.074)
Cadmium (g/g creatinine) 0.046* (0.042–0.052) 0.070 (0.067–0.072)
Cadmium (g/L urine) Mothers (N = 108) 98 0.199* (0.178–0.223) Mothers (N = 1685) 93.8 0.219 (0.211–0.228)
Cadmium (g/g creatinine) 0.182* (0.166–0.199) 0.196 (0.189–0.202)
Cotinine (g/L urine) Children (N = 120) 87 0.308 (0.244–0.387) Children (N = 1818) 57.6 0.797 (0.759–0.837)
Cotinine (g/g creatinine) 0.280 (0.222–0.353) 0.774 (0.736–0.815)
Cotinine (g/L urine) Mothers (N = 116) 86 0.916 (0.520–1.62) Mothers (N = 1800) 62.4 2.75 (2.41–3.14)
Cotinine (g/L creatinine) 0.813 (0.461–1.43) 2.45 (2.14–2.80)
N: sample size, LOQ: limit of quanitiﬁcation, GM:  geometric mean, 95% CI: 95% conﬁdenc
a data are from Den Hond et al. (2015), Supplemental Material.
* German cadmium results, not included in the DEMOCOPHES European analysis.
Fig. 1. Mercury concentrations in hair of mothers and their children by ﬁsh and
shellﬁsh consumption in German DEMOCOPHES.
Table 5
Correlation of the biomarkers measured in mother-child pairs in DEMOCOPHES in
Germany.
Biomarker rs p
Mercury 0.425 0.000
Cadmium 0.091 0.352
Cotinine 0.595 0.000
MEP  0.360 0.000
MBzP 0.524 0.000
MnBP 0.428 0.000
DiBP 0.400 0.000
DEHP (sum of MEHP + 5OH-MEHP + 5oxo-MEHP) 0.154 0.098
MEHP 0.256 0.006
5-OH-MEHP 0.159 0.088
5-oxo-MEHP 0.148 0.112
r
n
c
t
o
e
i
m
(
w
o
o
for molybdenum oxide or after reanalyzing the samples in anothers Spearman rank correlation, two-tailed test. Analyte g/L urine. Samples with uri-
ary creatinine concentrations below 300 mg/L or above 3000 mg/L were excluded.
oncentrations between mothers and their children indicate a rela-
ionship with dietary habits and in particular with consumption
f ﬁsh and other products from the aquatic environment (Castano
t al., 2015; Den Hond et al., 2015).
Although mercury in hair was not measured in comparable stud-
es in Germany, the results are in line with the determination of
ercury in blood in the German Environmental Survey for Children
GerES IV). In GerES IV the highest mercury concentration in blood
as 6.3 g/L for children aged 6–14 (Becker et al., 2008) and 0.2%
f the children exceeded the health based guidance value (HBM-I)
f mercury of 5 g/L blood (Schulz et al., 2012b; Apel et al., 2016).e interval.
The DEMOCOPHES data conﬁrm the result of GerES IV that mercury
exposure is not of great concern in Germany. Nevertheless as ﬁsh
and other seafood products are important elements of a healthy
diet and negative effects of even low mercury exposure levels have
been postulated (Bellanger et al., 2013; Karagas et al., 2012; Valent
et al., 2013), ongoing monitoring of the population for the current
exposure to mercury is warranted.
Determination of mercury in hair is accepted as a reliable esti-
mate of the internal dose (Harkins and Susten, 2003), it shows
a direct correlation with blood levels and provides a good long-
term marker of exposure to methyl mercury, but is not a marker
of inorganic mercury exposure (UNEP/WHO, 2008). Factors like
hair treatments, hair colour, ethnicity, age and external contami-
nation may  affect the incorporation of mercury in hair (Dakeishi
et al., 2005; McDowell et al., 2004). In Germany there is only
limited experience with mercury detection in scalp hair (Pesch
et al., 2002). Determination of mercury in hair has never been
applied in the GerES. This is due to the recommendation of the
German Human Biomonitoring Commission to focus on blood and
urine when measuring multiple substances in HBM studies as
hair is only a reliable matrix for mercury and not for other met-
als (Bundesgesundheitsblatt, 2005). However measuring mercury
in hair in the context of a harmonized study protocol, with the
COPHES guidelines and with comparable and quality-assured ana-
lytical procedures has broadened Germany’s experience and can
be considered as an additional surveillance method for mercury in
HBM studies, being less invasive than taking a blood sample.
3.3. Cadmium in urine
In the course of the study it became apparent that the ICP-MS-
method is not completely speciﬁc for the quantiﬁcation of cadmium
in urine. The interferences of molybdenum oxide and tin have a sub-
stantial effect on cadmium quantiﬁcation (Jarrett et al., 2008) and
the inﬂuence of molybdenum oxide, especially, had been underesti-
mated. Molybdenum oxide emerges from molybdenum content in
urine and cannot be removed completely. Newer ﬁndings indicate
that the molybdenum content in urine is generally high to such
a degree as it should not be neglected. Former measurements of
the German DEMOCOPHES samples excluded this fact and conse-
quently were not in line with the rest of the DEMOCOPHES study. As
COPHES QAU decided only to consider results of laboratories either
being successful in two  quality exercises with a required correctionexperienced laboratory, the German cadmium data were, therefore,
not considered in the DEMOCOPHES European analysis. However
after implementing a procedure that includes the correction of
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olybdenum oxide as required by the COPHES QAU, the German
aboratory undertook reanalysis of the DEMOCOPHES urine sam-
les. The individual molybdenum contents were determined and
he conversion of the molybdenum counts in cadmium counts was
arried out on the basis of the measurement of a special molybde-
um standard with known cadmium and molybdenum content.
his additional signal, which was not considered in the former
pproach, was subtracted from the cadmium signal in the reanal-
sis. Concomitantly with the reanalysis the laboratory ensured the
ccuracy of the revised procedure by the successful participation
n the German External Quality Assessment Scheme (G-EQUAS), an
nternational proﬁciency test program for human biomonitoring
arameters (Göen et al., 2012).
After reanalysis cadmium in urine was detected in 61% of the
hildren and in 98% of the mothers (Table 4). The cadmium con-
entrations ranged from <0.05 g/L to 0.23 g/L for children and
rom <0.05 g/L to 0.89 for mothers, being higher in mothers (GM
.199 g/L) than in children (0.051 g/L) (Supplementary Table
). There was no correlation between the cadmium values of the
hildren and their respective mothers (r = 0.091, Table 5). None of
he factors of exposure suspected to be associated with cadmium
oncentration in urine (for example age, smoking behavior, food
onsumption) was correlated with cadmium levels in urine, neither
n the children nor in the mothers.
After applying the required molybdenum correction, the cad-
ium concentrations in Germany can now be compared to the
ther DEMOCOPHES countries. The participating German children
ad a slightly lower cadmium GM compared to the other DEMO-
OPHES countries (0.051 g/L versus 0.071 g/L), the GM of the
others did not differ (Table 4). The cadmium GM of the chil-
ren was also slightly lower than the cadmium GM of 0.068 g/L,
easured in 3–14 years old children in GerES IV (Becker et al.,
008). However, due to the COPHES selection criteria, the German
EMOCOPHES participants were not representative for the German
opulation of this age. The current cadmium exposure of children
ged 3–17 years in Germany will be monitored in a respective rep-
esentative sample of the German population in the ongoing GerES
.
The German Human Biomonitoring Commission derived health
ased guidance values (HBM-I and HBM-II values) for cadmium
n urine of 0.5 g/L for children and 1.0 g/L for adults (Schulz
t al., 2012b; Apel et al., 2016). Biomonitoring equivalents (BE) were
erived for cadmium in urine and blood (Hays et al., 2008). None
f the German children or mothers exceeded the HBM-I or the BE
alues (Table 7).
.4. Cotinine in urine
Cotinine in urine was detected in 87% of the children and
n 86% of the mothers (Table 4). The maximum cotinine levels
easured were 22.4 g/L for children and 3420 g/L for mothers
Supplementary Table 1). The GM was 0.308 g/L for children and
.916 g/L for mothers, both were lower than the GM of the whole
EMOCOPHES sample (0.797 g/L for children and 2.75 g/L for
others, Table 4).
In GerES IV, a GM of 1.3 g/L was determined in a representa-
ive sample of 3–14 year old German children (Becker et al., 2008).
irect comparison however cannot be drawn as DEMOCOPHES was
 non-representative sample and the age range differed in both
tudy populations.
The wide range of cotinine concentrations observed in mothers
an be explained by their smoking behavior. Mothers who  were
mokers had a GM of 404 g/L, whereas the GM of mothers who
id not smoke was only 0.3 g/L. Of the mothers, 17.5% were daily
mokers, but all children were never-smokers (Table 3). Cotinine
oncentrations correlated highly between the children and theirFig. 2. Urinary cotinine concentrations in children by number of smokers in the
household.
mothers (r = 0.595, p < 0.001, Table 5). Moreover, as Fig. 2 shows,
urinary cotinine in children increased with the number of smokers
in the household.
It  was  reported that 8% of the children were exposed to envi-
ronmental tobacco smoke (ETS) at home and 47% outside their
home. Cotinine concentrations were signiﬁcantly elevated in non-
smoking mothers and children when exposed to ETS within the last
24 h.
The health impact of ETS on children is commonly recog-
nized (CDC, 2006). There is no safe level of exposure to ETS
regarding health impact on children and adults and there is also
evidence that implementing smoke-free environments is the only
effective way  to protect the population from the harmful effects
of exposure to ETS (WHO, 2007). Consequently, legislations on
smoke-free environments were introduced in the European Union
member countries in order to minimize or even prevent ETS
(EuropeanCommission, 2013). Germany passed a smoke free law
in 2007, but according to the Smoke Free Partnership it ranks as
a country with limited protection against ETS (SFP, 2011). Since
almost half of the children were exposed to ETS outside their home,
the results of this study suggest that there is further potential for
enhancing protection of children from ETS in Germany.
3.5. Phthalate metabolites in urine
The phthalate metabolites MEP, MBzP, MnBP and MiBP, 5OH-
MEHP, 5oxo-MEHP and cx-MEPP were detected in all German
children and their mothers, the primary DEHP-metabolite MEHP
was detected in 93% of the children and in 85% of the mothers.
Minimum and maximum values of the different phthalate metabo-
lites are provided in the Supplementary Table 2. The German
children had GMs  for MBzP and MiBP and the mothers had GMs
for MEP  and MBzP which did not differ from those of all DEMO-
COPHES countries. Compared to the whole DEMOCOPHES sample,
the German children had lower GMs  for MEP  and the sum of 3
DEHP-metabolites (MEHP, 5OH-MEHP and 5oxo-MEHP) (22.7 g/L
versus 34.4 g/L and 39.2 g/L versus 47.6 g/L) and a higher GM
for MnBP (46.1 g/L versus 34.8 g/L), whereas the German moth-
ers had lower GMs  for MiBP and the sum of 3 DEHP-metabolites
(25.1 g/L versus 30.1 g/L and 21.5 g/L versus 29.2 g/L) and
also a higher GM for MnBP (31.5 g/L versus 23.9 g/L) (Table 6),
hence showing some variation in the exposure pattern among the
European countries.
Most measured phthalate metabolite concentrations of children
and mothers were signiﬁcantly correlated, only 5OH-MEHP and
5oxo-MEHP did not reach signiﬁcance (Table 5). Compared to the
mothers, children had 42–82% higher GMs  of the urinary phthalate
metabolites MBzP, MnBP, MiBP and DEHP and a 42% lower GM of
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Table  6
Frequency of quantiﬁcation, geometric mean with 95% conﬁdence interval (in parentheses) of phthalate metabolites of children and their mothers in DEMOCOPHES in
Germany and in all DEMOCOPHES countries.
DEMOCOPHES in Germany All DEMOCOPHES countriesa
% >LOQ GM (95% CI) % >LOQ GM (95% CI)
MEP  (g/L urine) Children (N = 120) 100 22.7 (19.5–26.4) Children (N = 1816) 98.0 34.4 (32.8–36.0)
MEP  (g/g creatinine) 20.6 (18.1–23.5) 33.4 (31.9–34.9)
MEP  (g/L urine) Mothers (N = 116) 100 39.4 (32.3–48.1) Mothers (N = 1800) 95.2 48.2 (45.6–51.0)
MEP  (g/L creatinine) 35.0 (28.9–42.4) 42.9 (40.8–45.2)
MBzP  (g/L urine) Children (N = 120) 100 6.47 (5.31–7.89) Children (N = 1816) 95.2 7.15 (6.83–7.48)
MBzP  (g/g creatinine) 5.88 (4.94–7.00) 6.94 (6.66–7.24)
MBzP  (g/L urine) Mothers (N = 116) 100 4.55 (3.83–5.40) Mothers (N = 1800) 91.8 4.51 (4.31–4.72)
MBzP  (g/L creatinine) 4.03 (3.48–4.68) 4.02 (3.87–4.18)
MnBP(g/L  urine) Children (N = 120) 100 46.1 (40.0–53.0) Children (N = 1355) 99.9 34.8 (33.5–36.2)
MnBP (g/g creatinine) 41.9 (37.4–46.9) 34.0 (32.8–35.2)
MnBP (g/L urine) Mothers (N = 116) 100 31.5 (27.4–36.1) Mothers (N = 1347) 99.4 23.9 (23.0–24.9)
MnBP (g/L creatinine) 27.9 (25.3–30.8) 21.5 (20.8–22.2)
MiBP(g/L  urine) Children (N = 120) 100 40.9 (35.7–47.0) Children (N = 1355) 99.8 45.4 (43.6–47.3)
MiBP  (g/g creatinine) 37.2 (33.2–41.8) 44.3 (42.7–46.0)
MiBP  (g/L urine) Mothers (N = 116) 100 25.1 (22.1–28.4) Mothers (N = 1347) 99.4 30.1 (28.9–31.4)
MiBP  (g/L creatinine) 22.2 (20.2–24.5) 27.0 (26.1–28.0)
DEHPb (g/L urine) Children (N = 120) 93–100 39.2 (34.3–44.7) Children (N = 1816) 85.6 47.6 (46.0–49.3)
DEHPb (g/g creatinine) 35.6 (31.7–40.0) 46.2 (44.9–47.7)
DEHPb (g/L urine) Mothers (N = 116) 85–100 21.5 (18.7–24.8) Mothers (N = 1800) 81.6 29.2 (28.1–30.3)
DEHPb (g/L creatinine) 19.1 (17.2–21.3) 26.0 (25.2–26.9)
Abbrevations: N: sample size, LOQ: limit of quantiﬁcation, GM:  geometric mean, 95% CI: 95% conﬁdence interval.
a data are from Den Hond et al., 2015; Supplemental Material.
b The sum of the following 3 DEHP-metabolites were measured: MEHP + 5OH-MEHP +5oxo-MEHP.
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EP. These relations were found for all DEMOCOPHES countries
Den Hond et al., 2015). Additionally, similar ratios were found
ith respect to younger and older children (Fig. 3): 6–8 year old
hildren had 8–31% higher levels of MBzP, MnBP, MiBP and DEHP-
etabolites and 11% lower levels of MEP  than the children aged
–11 years. Besides age, several factors such as use of personal care
roducts, the consumption of cereals, hazelnut spread, ice cream
nd chewing gums, potential industrial phthalate contamination
n the neighborhood, and poly-vinyl chloride (PVC) materials at
ome were positively correlated with phthalate concentrations in
hildren and in mothers in all DEMOCOPHES countries (Den Hond
t al., 2015) or in individual DEMOCOPHES participating countries
Cutanda et al., 2015). For the German DEMOCOPHES participants
he use of fragrances and make-up were associated with higher
EP  concentrations in mothers, the consumption of chewing gum
ith higher DEHP-metabolite concentrations in children and thes) and older (9–11 years) children and of their mothers.
frequent consumption of cereals with elevated concentrations of
MBzP in both, children and mothers. MBzP, MnBP and MiBP concen-
trations in children and MnBP and MiBP concentrations in mothers
were higher for residents of the urban area than in residents of the
rural area. Self-reported neighbourhood exposure to an industrial
site with researcher deduced potential phthalate contamination
was correlated with higher MnBP and DEHP-metabolite concentra-
tions in children and with higher MnBP and MiBP concentrations
in mothers. MBzP and DEHP-metabolite concentrations in children
were associated with participant identiﬁed PVC materials in the
home.
Comparison of the German data with representative GerES
IV data of 3–14 year old German children analyzed for MBzP,
MnBP, MiBP and DEHP-metabolites in urine (17.5 g/L, 95.6 g/L,
94.3 g/L and 91.3 g/L) (Becker et al., 2009) revealed that the
concentrations reported here amounted to only 37–52% of those
6 iene and Environmental Health 220 (2017) 686–696
m
I
r
t
p
y
M
1
r
E
M
e
p
d
e
e
I
2
w
c
o
M
H
B
p
s
e
c
c
T
a
e
h
l
a
n
i
p
f
i
4
D
s
i
f
H
t
a
c
o
a
l
w
a
u
e
r
t
O
C
O
PH
ES
 
p
ar
ti
ci
p
an
ts
 
ex
ce
ed
in
g 
h
ea
lt
h
 
ba
se
d
 
gu
id
an
ce
 
va
lu
es
.
of
 
ex
p
os
u
re
So
u
rc
e  
of
 
h
ea
lt
h
-b
as
ed
 
gu
id
an
ce
 
va
lu
es
: 
V
al
u
es
a
: 
%
 
ex
ce
ed
in
g 
h
ea
lt
h
 
ba
se
d
 
gu
id
an
ce
 
va
lu
e
C
h
il
d
re
n
 
6–
11
 
ye
ar
s
M
ot
h
er
s 
28
–4
5  
ye
ar
s
D
EM
O
C
O
PH
ES
 
G
er
ES
 
IV
D
EM
O
C
O
PH
ES
JE
FC
A
-g
u
id
el
in
e  
ba
se
d
 
on
 
U
SE
PA
 
re
fe
re
n
ce
 
d
os
e
2.
3 

g/
g  
h
ai
r
0.
0%
 
–  
0.
0%
1.
0  

g/
g 
h
ai
r 
0.
8%
 
– 
0.
8%
H
B
M
-I
 
va
lu
e  
B
E  
ba
se
d
 
on
 
A
TS
D
R
 
ch
ro
n
ic
 
M
R
L
0.
5 

g/
L  
u
ri
n
e  
(c
h
il
d
re
n
 
an
d
 
ad
ol
es
ce
n
ts
)
0.
0%
 
0.
3%
1.
0  

g/
L 
u
ri
n
e 
(a
d
u
lt
s)
 
0.
0%
1.
2  

g/
L
0.
0%
 
0.
0%
re
d
 
as
 
M
EP
:
B
E 
ba
se
d
 
on
 
U
SE
PA
 
su
bc
h
ro
n
ic
 
R
fD
18
,0
00
 

g/
L  
u
ri
n
e
0.
0%
 
–  
0.
0%
u
re
s  
as
 
M
B
zP
: 
B
E  
ba
se
d
 
on
 
U
SE
PA
 
su
bc
ro
n
ic
 
R
fD
 
38
00
 

g/
L 
0.
0%
 
0.
0%
 
0.
0%
su
re
s  
as
 
M
n
B
P:
B
E 
ba
se
d
 
on
 
EF
SA
 
su
bc
ro
n
ic
 
TD
I
20
0 

g/
L  
u
ri
n
e
4.
2%
 
12
.2
%
 
0.
9%
su
re
d
 
as
 
th
e  
su
m
 
of
li
te
sb
:
H
B
M
-I
 
va
lu
e
50
0  

g/
L  
u
ri
n
e  
(c
h
il
d
re
n
 
ag
ed
 
6–
13
)
1.
7.
%
 
1.
4%
30
0  

g/
L 
u
ri
n
e 
(w
om
en
 
in
 
ch
il
d
be
ar
in
g 
ag
e)
 
0.
0%
li
te
sc
:
B
E 
ba
se
d
 
on
 
U
SE
PA
 
ch
ro
n
ic
 
R
fD
26
0 

g/
L
1.
7%
 
6.
3%
 
0.
9%
li
te
sd
: 
B
E 
ba
se
d
 
on
 
U
SE
PA
 
ch
ro
n
ic
 
R
fD
 
40
0 

g/
L 
2.
5%
 
6.
5%
 
0.
0%
s:
 
G
er
ES
 
IV
:  G
er
m
an
 
En
vi
ro
n
m
en
ta
l S
u
rv
ey
 
IV
 
(2
00
3–
20
06
),
 
JE
FC
A
: J
oi
n
t 
FA
O
/W
H
O
 
Ex
p
er
t 
C
om
m
it
te
e 
on
 
Fo
od
 
A
d
d
it
iv
es
, U
SE
PA
: U
n
it
ed
 
St
at
es
 
En
vi
ro
n
m
en
ta
l P
ro
te
ct
io
n
 
A
ge
n
cy
, H
B
M
-I
: h
u
m
an
 
bi
om
on
it
or
in
g 
va
lu
e
it
or
in
g  
eq
u
iv
al
en
t,
 
A
TS
D
R
:  
A
ge
n
cy
 
fo
r  
To
xi
c  
Su
bs
ta
n
ce
s  
an
d
 
D
is
ea
se
 
R
eg
is
tr
y,
 
M
R
L:
 
m
in
im
al
 
ri
sk
 
le
ve
l, 
R
fD
: 
re
fe
re
n
ce
 
d
os
e,
 
EF
SA
: 
Eu
ro
p
ea
n
 
Fo
od
 
Sa
fe
ty
 
A
u
th
or
it
y,
 
TD
I:
 
to
le
ra
bl
e 
d
ai
ly
 
in
ta
ke
.
se
d
 
gu
id
an
ce
 
va
lu
es
 
fo
r 
m
er
cu
ry
: 
W
H
O
 
G
u
id
el
in
e,
 
20
04
 
an
d
 
N
R
C
, 2
00
0;
 
ca
d
m
iu
m
: 
Sc
h
u
lz
 
et
 
al
., 
20
12
b 
an
d
 
H
ay
s 
et
 
al
., 
20
08
; 
D
EP
, B
B
zP
, D
n
B
P:
 
A
yl
w
ar
d
 
et
 
al
., 
20
09
a;
 
D
EH
P:
 
Sc
h
u
lz
 
et
 
al
., 
20
12
b 
an
d
 
A
yl
w
ar
d
 
et
 
al
.,
P 
+ 
5o
xo
-M
EH
P.
O
H
-M
EH
P 
+ 
5o
xo
-M
EH
P.
O
H
-M
EH
P 
+ 
5o
xo
-M
EH
P 
+ 
cx
-M
EP
P.94 G. Schwedler et al. / International Journal of Hyg
easured in GerES IV. Although the DEMOCOPHES and the GerES
V results cannot be compared directly because of the different age
ange, the lower concentrations found in DEMOCOPHES correspond
o a decline of MBzP, MnBP and DEHP-metabolites observed in sam-
les of the German Environmental Specimen Bank of students in the
ears 2002–2008 (medians declined from 7.8 g/L to 3.8 g/L for
BzP, from 65.4 g/L to 19.6 g/L for MnBP, and from 40.5 g/L to
9.3 g/L for DEHP-metabolites) (Göen et al., 2011). This may  be a
esult of regulation on phthalates in consumer products (EC, 1999;
U, 2005).
Health based guidance values are available for MEP, MBzP,
nBP and for different combinations of DEHP metabolites (Aylward
t al., 2009a,b; Schulz et al., 2012b; Apel et al., 2016). The pro-
ortion of children and mothers, exceeding either HBM-I values
erived by the German Human Biomonitoring Commission (Schulz
t al., 2012b; Apel et al., 2016) or BE values, derived by Aylward
t al. (2009a,b), are shown in Table 7. Compared to the HBM-
 value of 500 g/L, 1.7% of the children had concentrations of
 DEHP-metabolites (5OH-MEHP + 5oxo-MEHP) above the limit
here adverse health effects cannot be excluded with sufﬁ-
ient certainty. Similarly, 2.5% of children exceeded the BE value
f 4 metabolites of DEHP (MEHP + 5OH-MEHP + 5oxo-MEHP + cx-
EPP). Guidance values of MEP  and MBzP were not exceeded.
owever, 4.2% of the children and 0.9% of the mothers exceeded the
E value for MnBP. These results show that even though average
hthalate concentrations are lower in this study than in previous
tudies, a non-negligible proportion of children and mothers still
xceed health based guidance values, indicating reasons for con-
ern.
The results of DEMOCOPHES related to phthalates conﬁrm that
hildren are exposed concurrently to a mixture of phthalates.
here is evidence, that phthalates can produce cumulative, additive
dverse effects (Christiansen et al., 2009; Gray, 2008; Howdeshell
t al., 2007). If cumulative exposure is taken into account, an even
igher proportion of the population is expected to have exposure
evels higher than health based guidance values. Therefore, evalu-
ting the cumulative exposure to all endocrine active phthalates is
eeded (Lioy et al., 2015; NRC, 2008; Wittassek et al., 2011). Ongo-
ng human biomonitoring of established, as well as of upcoming
hthalates and their substitutes is needed to support actions to
urther reduce exposure in the general population and especially
n high exposure groups.
. Conclusion
Germany conducted the human biomonitoring pilot study
EMOCOPHES as one of 17 European countries. The harmonized
tudy protocol could be applied with only minor adaptations not
nterfering with comparability. However, the participation rate was
airly low and measures to improve it must be undertaken in future
BM studies.
Although the studied population samples were not representa-
ive for the respective countries, the harmonized study protocol
llowed the collection of comparable HBM data in the different
ountries thus enabling elaboration of a broader European picture
f the exposure to chemicals. Including males in the future will
dd to the picture. Compared to the European levels, Germany had
ower levels for mercury and cotinine. This shows that European-
ide actions only relying on German data could lead to actions that
re not sufﬁciently protective for Europe.
Although there are regulations on phthalates in consumer prod-
cts, health based guidance values for some phthalates were
xceeded in German and in other European participants. These
esults indicate that human exposure to pollutants must continue
o be monitored and reduced in Europe and in Germany. Ta
b
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Continuous HBM is necessary to track changes of pollutant
xposure levels over time. In Germany, all chemicals measured in
EMOCOPHES were also determined in the population representa-
ive GerES and time trends are analysed in samples of the German
nvironmental Specimen Bank. The added value of participating
n DEMOCOPHES was to increase our understanding of how expo-
ure varies across Europe and to contribute to the development of
 coherent and sustainable system of comparable HBM measure-
ents for pollutant exposure estimation. Germany will continue to
ooperate on the harmonisation of European human biomonitor-
ng, currently through the HBM4EU Initiative, in order to support
he EU chemicals regulation with the best possible exposure data
nd for the protection of all Europeans against environmental
ealth risks.
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